The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity-Reference-Cited by-同舟云学术

The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity

Published:2017-12-01 Issue:3 Volume:18 Page:268-283
ISSN:1530-7905
Container-title:Cardiovascular Toxicology
language:en
Short-container-title:Cardiovasc Toxicol

Author:

Maayah Zaid H.,Abdelhamid Ghada,Elshenawy Osama H.,El-Sherbeni Ahmed A.,Althurwi Hassan N.,McGinn Erica,Dawood Doaa,Alammari Ahmad H.,El-Kadi Ayman O. S.^ORCID

Funder

Canadian Institutes of Health Research

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology

Link

http://link.springer.com/article/10.1007/s12012-017-9437-8/fulltext.html

Reference66 articles.

1. Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004). Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacological Reviews, 56, 185–229.

2. Cernecka, H., Doka, G., Srankova, J., Pivackova, L., Malikova, E., Galkova, K., et al. (2016). Ramipril restores PPARbeta/delta and PPARgamma expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy chain ratio shift in severe anthracycline-induced cardiomyopathy in rat. European Journal of Pharmacology, 791, 244–253.

3. Takemura, G., & Fujiwara, H. (2007). Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Progress in Cardiovascular Diseases, 49, 330–352.

4. Deng, S., Yan, T., Jendrny, C., Nemecek, A., Vincetic, M., Godtel-Armbrust, U., et al. (2014). Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms. BMC Cancer, 14, 842.

5. Roman, R. J. (2002). P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiological Reviews, 82, 131–185.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of cytochrome P450 epoxygenase promotes endothelium-to-mesenchymal transition and exacerbates doxorubicin-induced cardiovascular toxicity;Molecular Biology Reports;2024-07-27

2. Assessment of Native Myocardial T1 Mapping for Early Detection of Anthracycline-Induced Cardiotoxicity in Patients with Cancer: a Systematic Review and Meta-analysis;Cardiovascular Toxicology;2024-05-03

3. Enhancing cancer immunotherapy via inhibition of soluble epoxide hydrolase;Proceedings of the National Academy of Sciences;2024-02-08

4. Reducing oxidative stress may be important for treating pirarubicin‑induced cardiotoxicity with schisandrin B;Experimental and Therapeutic Medicine;2021-11-23

5. The genetic underpinnings of anthracycline‐induced cardiomyopathy predisposition;Clinical Genetics;2021-05-02